UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma

Cancer, 2014-06, Vol.120 (12), p.1794-1799

2014

Volltextzugriff (PDF)

Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy

The Journal of urology, 2014-01, Vol.191 (1), p.40-47

2014

Volltextzugriff (PDF)

New Insights into Subtypes of Invasive Bladder Cancer: Considerations of the Clinician

European urology, 2014-10, Vol.66 (4), p.609-610

2014

Volltextzugriff (PDF)

Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin

European urology, 2016-02, Vol.69 (2), p.197-200

2016

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center

European urology, 2013-08, Vol.64 (2), p.307-313

2013

Volltextzugriff (PDF)

New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine

Clinical cancer research, 2011-05, Vol.17 (9), p.2608-2612

2011

Volltextzugriff (PDF)

Evaluation of Genetic Variants in MicroRNA-Related Genes and Risk of Bladder Cancer

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2530-2537

2008

Volltextzugriff (PDF)

Clinical Trial Design for the Development of New Therapies for Nonmuscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public Workshop

Urology, 2014-02, Vol.83 (2), p.262-265

2014

Volltextzugriff (PDF)

Micropapillary bladder cancer : A review of the University of Texas M. D. Anderson cancer center experience with 100 consecutive patients

Cancer, 2007-07, Vol.110 (1), p.62-67

2007

Volltextzugriff (PDF)

Urachal carcinoma: a pathologic and clinical study of 46 cases

Human pathology, 2015-12, Vol.46 (12), p.1808-1814

2015

Volltextzugriff (PDF)

Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video‐endoscopic inguinal lymphadenectomy in patients with penile carcinoma

BJU international, 2013-06, Vol.111 (7), p.1068-1074

2013

Volltextzugriff (PDF)

Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval

Frontiers in immunology, 2023-08, Vol.14, p.1260498

2023

Volltextzugriff (PDF)

The impact of variant histology on the outcome of bladder cancer treated with curative intent

Urologic oncology, 2009, Vol.27 (1), p.3-7

2009

Volltextzugriff (PDF)

Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high‐risk upper tract transitional cell carcinoma

Cancer, 2010-07, Vol.116 (13), p.3127-3134

2010

Volltextzugriff (PDF)

The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder

Clinical cancer research, 2010-09, Vol.16 (17), p.4461-4467

2010

Volltextzugriff (PDF)

Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer

Molecular cancer therapeutics, 2013-07, Vol.12 (7), p.1245-1254

2013

Volltextzugriff (PDF)

Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients

The Journal of urology, 2010-06, Vol.183 (6), p.2165-2170

2010

Volltextzugriff (PDF)

Bladder cancer angiogenesis and metastasis--translation from murine model to clinical trial

Cancer and metastasis reviews, 2007-12, Vol.26 (3-4), p.623-634

2007

Volltextzugriff (PDF)

Differential expression of GATA-3 in urothelial carcinoma variants

Human pathology, 2014-07, Vol.45 (7), p.1466-1472

2014

Volltextzugriff (PDF)

Phase II Clinical Trial of Neoadjuvant Alternating Doublet Chemotherapy With Ifosfamide/Doxorubicin and Etoposide/Cisplatin in Small-Cell Urothelial Cancer

Journal of clinical oncology, 2009-06, Vol.27 (16), p.2592-2597

2009

Volltextzugriff (PDF)

Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression

Cancer research (Chicago, Ill.), 2007-02, Vol.67 (4), p.1430-1435

2007

Volltextzugriff (PDF)

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

Cancer cell, 2014-02, Vol.25 (2), p.152-165

2014

Volltextzugriff (PDF)

Clinical model of lifetime cost of treating bladder cancer and associated complications

Urology (Ridgewood, N.J.), 2006-09, Vol.68 (3), p.549-553

2006

Volltextzugriff (PDF)

The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non‐muscle‐invasive bladder cancer treated with bacillus Calmette–Guérin

BJU international, 2021-07, Vol.128 (1), p.65-71

2021

Volltextzugriff (PDF)

Lymph Node Density Is Superior to TNM Nodal Status in Predicting Disease-Specific Survival After Radical Cystectomy for Bladder Cancer: Analysis of Pooled Data From MDACC and MSKCC

Journal of clinical oncology, 2008-01, Vol.26 (1), p.121-126

2008

Volltextzugriff (PDF)

1 – 25 von 604

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(584)
Mit Volltextzugriff
(406)

Publikationsform

Sprache

Englisch
(603)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(370)
Life Sciences & Biomedicine
(363)
Humans
(329)
Male
(231)
Urology & Nephrology
(205)
Biological And Medical Sciences
(192)
Medical Sciences
(191)
Female
(187)
Oncology
(172)
Aged
(166)
Middle Aged
(164)
Urinary Bladder Neoplasms - Pathology
(160)
Nephrology. Urinary Tract Diseases
(144)
Bladder Cancer
(138)
Tumors Of The Urinary System
(126)
Urinary Tract. Prostate Gland
(118)
Urology
(115)
Urinary Bladder Neoplasms - Surgery
(91)
Retrospective Studies
(80)
Urinary Bladder Neoplasms - Drug Therapy
(80)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma

Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy

New Insights into Subtypes of Invasive Bladder Cancer: Considerations of the Clinician

Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin

Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center

New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine

Evaluation of Genetic Variants in MicroRNA-Related Genes and Risk of Bladder Cancer

Clinical Trial Design for the Development of New Therapies for Nonmuscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public Workshop

Micropapillary bladder cancer : A review of the University of Texas M. D. Anderson cancer center experience with 100 consecutive patients

Urachal carcinoma: a pathologic and clinical study of 46 cases

Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video‐endoscopic inguinal lymphadenectomy in patients with penile carcinoma

Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval

The impact of variant histology on the outcome of bladder cancer treated with curative intent

Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high‐risk upper tract transitional cell carcinoma

The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder

Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer

Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients

Bladder cancer angiogenesis and metastasis--translation from murine model to clinical trial

Differential expression of GATA-3 in urothelial carcinoma variants

Phase II Clinical Trial of Neoadjuvant Alternating Doublet Chemotherapy With Ifosfamide/Doxorubicin and Etoposide/Cisplatin in Small-Cell Urothelial Cancer

Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

Clinical model of lifetime cost of treating bladder cancer and associated complications

The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non‐muscle‐invasive bladder cancer treated with bacillus Calmette–Guérin

Lymph Node Density Is Superior to TNM Nodal Status in Predicting Disease-Specific Survival After Radical Cystectomy for Bladder Cancer: Analysis of Pooled Data From MDACC and MSKCC

Suchergebnisse filtern